Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$9.57M Buy
239,141
+33,073
+16% +$1.3M 0.85% 24
2018
Q1
$8.26M Buy
206,068
+18,439
+10% +$767K 0.78% 29
2017
Q4
$8.07M Buy
187,629
+11,264
+6% +$519K 0.79% 28
2017
Q3
$8.78M Buy
176,365
+10,369
+6% +$502K 0.95% 21
2017
Q2
$7.95M Buy
165,996
+8,511
+5% +$407K 0.91% 20
2017
Q1
$7.13M Buy
157,485
+8,702
+6% +$369K 0.87% 24
2016
Q4
$6.01M Buy
+148,783
New +$5.86M 0.77% 27

Other funds holding SNY

Edge Advisors's SNY Position: Q2 2018 in Review

Edge Advisors increased its Sanofi (SNY) stake by 16% in Q2 2018, buying an estimated $1.3M and bringing the position to 239,141 shares worth $9.57M. The position accounts for 0.85% of the portfolio, ranked #24.

Edge Advisors first reported a position in SNY in Q4 2016 and has held it in 7 quarters since. 478 funds tracked by Wall St. Rank hold SNY as of Q2 2018.

  • Edge Advisors held 239,141 shares of Sanofi worth $9.57M as of Q2 2018.
  • Edge Advisors bought 33,073 Sanofi shares in Q2 2018, an estimated $1.3M.
  • Sanofi made up 0.85% of Edge Advisors's portfolio in Q2 2018, its #24 holding.
  • Edge Advisors first reported a position in Sanofi in Q4 2016 and has held it in 7 quarters since.
  • 478 funds tracked by Wall St. Rank held Sanofi as of Q2 2018.

Based on Edge Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.